American Renal Associates (ARA) Tops Q4 EPS by 3c

American Renal Associates (NYSE: ARA) reported Q4 EPS of $0.18, $0.03 better than the analyst estimate of $0.15. Revenue for the quarter came in at $194.4 million versus the consensus estimate of $195.32 million.

For earnings history and earnings-related data on American Renal Associates (ARA) click here.

You May Also Be Interested In

• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
• Applied Industrial Technologies (AIT) Tops Q4 EPS by 25c, Beats on Revenue; Offers FY27 EPS Guidance
• Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance